| scholarly article | Q13442814 |
| P2093 | author name string | Howley PM | |
| Ham J | |||
| Yaniv M | |||
| Dostatni N | |||
| Lambert PF | |||
| Sousa R | |||
| P433 | issue | 9 | |
| P304 | page(s) | 1657-1671 | |
| P577 | publication date | 1991-09-01 | |
| P1433 | published in | Genes & Development | Q1524533 |
| P1476 | title | The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex | |
| P478 | volume | 5 |
| Q41452187 | A DNA sequence required for geminivirus replication also mediates transcriptional regulation |
| Q33785972 | A cis repression sequence adjacent to the transcription start site of the human cytomegalovirus US3 gene is required to down regulate gene expression at early and late times after infection |
| Q34158732 | A point mutation in the DNA-binding domain of HPV-2 E2 protein increases its DNA-binding capacity and reverses its transcriptional regulatory activity on the viral early promoter |
| Q33558774 | Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression |
| Q33961239 | Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex |
| Q39871942 | Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region |
| Q33292465 | Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB |
| Q24676251 | Brd4 links chromatin targeting to HPV transcriptional silencing |
| Q37350422 | Cellular and molecular biological aspects of cervical intraepithelial neoplasia |
| Q38358593 | Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability |
| Q24294198 | Cloning and chromosomal mapping of a human immunodeficiency virus 1 "TATA" element modulatory factor |
| Q40309052 | Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins |
| Q40790439 | Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. |
| Q47920467 | Cortistatin and somatostatin mRNAs are differentially regulated in response to kainate |
| Q73174536 | DNA binding and bending by the human papillomavirus type 16 E2 protein. Recognition of an extended binding site |
| Q40015385 | Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes |
| Q39642192 | Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31 |
| Q39877539 | Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein |
| Q35011943 | During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element |
| Q71747791 | E2 proteins: modulators of papillomavirus transcription and replication |
| Q39872981 | E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors |
| Q35635180 | E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein |
| Q35871772 | Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses |
| Q38317483 | Ex vivo regulation of specific gene expression by nanomolar concentration of double-stranded dumbbell oligonucleotides. |
| Q24532089 | Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis |
| Q99212575 | Functional evaluation of human papillomavirus type 31 long control region variants |
| Q36561445 | Functional interaction between p53, the TATA-binding protein (TBP), andTBP-associated factors in vivo. |
| Q40728097 | GATA suppresses erythropoietin gene expression through GATA site in mouse erythropoietin gene promoter |
| Q37424075 | Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells |
| Q33734803 | Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression |
| Q38913348 | HPV 16 E2 binding sites 1 and 2 become more methylated than E2 binding site 4 during cervical carcinogenesis |
| Q47398540 | HPV Replication Regulation by Acetylation of a Conserved Lysine in the E2 Protein. |
| Q40789545 | Heterodimeric Drosophila gap gene protein complexes acting as transcriptional repressors |
| Q35230930 | How do eukaryotic activator proteins stimulate the rate of transcription by RNA polymerase II? |
| Q34338679 | Human TATA binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing E1-E2 protein complex formation on the viral origin of replication |
| Q36627345 | Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. |
| Q34467609 | Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. |
| Q33807681 | Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase |
| Q38348785 | Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes. |
| Q36550902 | Human papillomaviruses and cervical cancer |
| Q40771880 | Human tumor growth is inhibited by a vaccinia virus carrying the E2 gene of bovine papillomavirus |
| Q36650345 | Identification and characterization of novel promoters in the genome of human papillomavirus type 18. |
| Q73187749 | Identification of cis-regulatory elements in the upstream regulatory region of human papillomavirus type 59 |
| Q36649427 | Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene |
| Q37698157 | Inhibition of the association of RNA polymerase II with the preinitiation complex by a viral transcriptional repressor |
| Q40199714 | Interaction of papillomavirus E2 protein with the Brm chromatin remodeling complex leads to enhanced transcriptional activation. |
| Q41862182 | Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression. |
| Q74609119 | Intratype HPV16 sequence variation within LCR of isolates from asymptomatic carriers and cervical cancers |
| Q40231265 | Kinetic and equilibrium binding studies of the human papillomavirus type-16 transcription regulatory protein E2 interacting with core enhancer elements |
| Q36636823 | Low-affinity E2-binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter. |
| Q33802567 | Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition |
| Q37060103 | Methylation Patterns of Papillomavirus DNA, Its Influence on E2 Function, and Implications in Viral Infection |
| Q33865760 | Molecular mechanism of carcinogenesis by human papillomavirus-16. |
| Q41535741 | Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription. |
| Q36425963 | Multifunctional transcription factor YY1: a therapeutic target in human cancer? |
| Q40379237 | Nucleo-cytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis. |
| Q40932326 | Papillomavirus E2 induces p53-independent apoptosis in HeLa cells |
| Q34676199 | Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways |
| Q41159507 | Papillomavirus infections--a major cause of human cancers |
| Q34349416 | Pathogenesis of human papillomaviruses in differentiating epithelia |
| Q72856893 | Promoter specificity and deletion analysis of three heat stress transcription factors of tomato |
| Q33888338 | Regulation of Drosophila Adh promoter switching by an initiator-targeted repression mechanism |
| Q57475469 | Regulation of HPV transcription |
| Q38110976 | Regulatory elements in the viral genome |
| Q36651655 | Repression of bovine papillomavirus type 1 transcription by the E1 replication protein. |
| Q33799928 | Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells. |
| Q24324023 | Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function |
| Q38956512 | SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6/E7 promoter |
| Q34360259 | Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1. |
| Q40048684 | Site-specific inhibition of RNA polymerase II preinitiation complex assembly by human cytomegalovirus IE86 protein. |
| Q39606345 | Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain |
| Q28247009 | Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex |
| Q35852233 | Suppression of cellular proliferation by the papillomavirus E2 protein |
| Q33783002 | Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. |
| Q40043548 | The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter. |
| Q40535614 | The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18 |
| Q36636897 | The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter |
| Q37630368 | The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. |
| Q39602415 | The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31. |
| Q42772702 | The HPV E2-Host Protein-Protein Interactions: A Complex Hijacking of the Cellular Network. |
| Q38299741 | The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. |
| Q36627235 | The bovine papillomavirus type 1 (BPV1) replication protein E1 modulates transcriptional activation by interacting with BPV1 E2. |
| Q41301893 | The genetic program of genital human papillomaviruses in infection and cancer |
| Q39590559 | The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association |
| Q36636087 | The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. |
| Q24530051 | The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat |
| Q37198619 | The papillomavirus E2 proteins |
| Q35571503 | The regulatory E2 proteins of human genital papillomaviruses are pro-apoptotic |
| Q39355106 | The truncated C-terminal E2 (E2-TR) protein of bovine papillomavirus (BPV) type-1 is a transactivator that modulates transcription in vivo and in vitro in a manner distinct from the E2-TA and E8^E2 gene products |
| Q39501471 | The use of a human papillomavirus 18 promoter for tissue-specific expression in cervical carcinoma cells |
| Q33782708 | Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines |
| Q35899069 | Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes. |
| Q38337180 | Transcription factor YY1 represses cell-free replication from human papillomavirus origins. |
| Q34150137 | Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding |
| Q37343877 | Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma |
| Q24337465 | Transcriptional repression by a novel member of the bZIP family of transcription factors |
| Q24307916 | Transcriptional repression of human immunodeficiency virus type 1 by AP-4 |
| Q38561398 | Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression. |
| Q36607707 | Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma |
| Q35869296 | YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. |
| Q40008754 | mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication |
| Q36636419 | trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors |
Search more.